摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-ethylcarboxylate-2,3,3a,9a-tetrahydro-3-hydroxy-2-hydroxymethyl-8H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-8-one | 1215184-78-3

中文名称
——
中文别名
——
英文名称
7-ethylcarboxylate-2,3,3a,9a-tetrahydro-3-hydroxy-2-hydroxymethyl-8H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-8-one
英文别名
ethyl (2R,4R,5R,6S)-5-hydroxy-4-(hydroxymethyl)-12-oxo-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,10-diene-11-carboxylate
7-ethylcarboxylate-2,3,3a,9a-tetrahydro-3-hydroxy-2-hydroxymethyl-8H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-8-one化学式
CAS
1215184-78-3
化学式
C12H14N2O7
mdl
——
分子量
298.252
InChiKey
HTNCBIKOCBANCS-BDNRQGISSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.8
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    118
  • 氢给体数:
    2
  • 氢受体数:
    8

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    7-ethylcarboxylate-2,3,3a,9a-tetrahydro-3-hydroxy-2-hydroxymethyl-8H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-8-oneammonium hydroxide 作用下, 以 甲醇 为溶剂, 反应 4.0h, 以48%的产率得到ethyl 3-[3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
    参考文献:
    名称:
    Synthesis and in vitro cytostatic activity of new β - d -arabino furan[1′,2′:4,5]oxazolo- and arabino-pyrimidinone derivatives
    摘要:
    A series of nucleoside derivatives was obtained via heteroatom annulation of the amino oxazoline Of D(-)-arabinose. Unequivocal proofs for the stereostructure of some new arabinosyl pyrimidinone derivatives were obtained by X-ray structure analysis. These newly synthesized compounds were then evaluated for their cytostatic activity against murine leukemia (L1210), and human T-lymphocytes (Molt 4/C8 and CEM). Of all the compounds in the series, the protected silylated tricyclic fused pyrimidinone 10 showed the most significant antitumor activity against murine leukemia L1210 (IC50 = 6 mu M), and human T-lymphocytes cells Molt 4/C8 (IC50 = 7.9 mu M) and CEM/0 cell lines (IC50 = 7.5 mu M). None of the compounds exhibited significant antiviral inhibitory activities. (C) 2009 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2009.10.032
  • 作为产物:
    描述:
    乙氧基甲叉丙二酸二乙酯2-amino-β-D-arabinofurano[1',2':4,5]-oxazoline乙醇 为溶剂, 反应 12.0h, 以43%的产率得到7-ethylcarboxylate-2,3,3a,9a-tetrahydro-3-hydroxy-2-hydroxymethyl-8H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-8-one
    参考文献:
    名称:
    Synthesis and in vitro cytostatic activity of new β - d -arabino furan[1′,2′:4,5]oxazolo- and arabino-pyrimidinone derivatives
    摘要:
    A series of nucleoside derivatives was obtained via heteroatom annulation of the amino oxazoline Of D(-)-arabinose. Unequivocal proofs for the stereostructure of some new arabinosyl pyrimidinone derivatives were obtained by X-ray structure analysis. These newly synthesized compounds were then evaluated for their cytostatic activity against murine leukemia (L1210), and human T-lymphocytes (Molt 4/C8 and CEM). Of all the compounds in the series, the protected silylated tricyclic fused pyrimidinone 10 showed the most significant antitumor activity against murine leukemia L1210 (IC50 = 6 mu M), and human T-lymphocytes cells Molt 4/C8 (IC50 = 7.9 mu M) and CEM/0 cell lines (IC50 = 7.5 mu M). None of the compounds exhibited significant antiviral inhibitory activities. (C) 2009 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2009.10.032
点击查看最新优质反应信息

文献信息

  • Synthesis and in vitro cytostatic activity of new β - d -arabino furan[1′,2′:4,5]oxazolo- and arabino-pyrimidinone derivatives
    作者:Jean-Jacques Bosc、Laurent Latxague、Jean-Michel Léger、Jan Balzarini、Isabelle Forfar、Christian Jarry、Jean Guillon
    DOI:10.1016/j.ejmech.2009.10.032
    日期:2010.2
    A series of nucleoside derivatives was obtained via heteroatom annulation of the amino oxazoline Of D(-)-arabinose. Unequivocal proofs for the stereostructure of some new arabinosyl pyrimidinone derivatives were obtained by X-ray structure analysis. These newly synthesized compounds were then evaluated for their cytostatic activity against murine leukemia (L1210), and human T-lymphocytes (Molt 4/C8 and CEM). Of all the compounds in the series, the protected silylated tricyclic fused pyrimidinone 10 showed the most significant antitumor activity against murine leukemia L1210 (IC50 = 6 mu M), and human T-lymphocytes cells Molt 4/C8 (IC50 = 7.9 mu M) and CEM/0 cell lines (IC50 = 7.5 mu M). None of the compounds exhibited significant antiviral inhibitory activities. (C) 2009 Elsevier Masson SAS. All rights reserved.
查看更多